PubMed=26607962; DOI=10.1038/srep17258; PMCID=PMC4660465
Canham M.A., Van Deusen A.L., Brison D.R., De Sousa P.A., Downie J.M., Devito L.G., Hewitt Z.A., Ilic D., Kimber S.J., Moore H.D., Murray H., Kunath T.
The molecular karyotype of 25 clinical-grade human embryonic stem cell lines.
Sci. Rep. 5:17258-17258(2015)

PubMed=28445466; DOI=10.1038/nature22312; PMCID=PMC5427175
Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C., Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G., Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A., Eggan K.C.
Human pluripotent stem cells recurrently acquire and expand dominant negative p53 mutations.
Nature 545:229-233(2017)

PubMed=28583200; DOI=10.1186/s13287-017-0561-y; PMCID=PMC5460457
Ye J.-P., Bates N., Soteriou D., Grady L., Edmond C., Ross A., Kerby A., Lewis P.A., Adeniyi T., Wright R., Poulton K.V., Lowe M., Kimber S.J., Brison D.R.
High quality clinical grade human embryonic stem cell lines derived from fresh discarded embryos.
Stem Cell Res. Ther. 8:128.1-128.13(2017)